| DC Field | Value | Language |
|---|
| dc.contributor.author | Stupakova, E. G. | - |
| dc.contributor.author | Lazareva, G. A. | - |
| dc.contributor.author | Gureev, V. V. | - |
| dc.contributor.author | Dolzhikova, I. N. | - |
| dc.contributor.author | Zhilinkova, L. A. | - |
| dc.date.accessioned | 2022-04-24T10:16:24Z | - |
| dc.date.available | 2022-04-24T10:16:24Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | L-NAME-induced preeclampsia: correction of functional disorders of the hemostasis system with resveratrol and nicorandil / E.G. Stupakova [et al.] // Research Results in Pharmacology. - 2019. - Vol. 5, № 2.- P. 1-12. - Doi: 10.3897/rrpharmacology.5.35316. - Refer.: p. 9-11. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46310 | - |
| dc.description.abstract | Preeclampsia is a formidable disease of the second half of pregnancy, leading to severe complications, including disability and even death. Many authors have recognized the correlation between the severity of preeclampsia and the degree of disturbances in the hemostasis system. In this regard, the objective of this study was to assess inhibition of platelet aggregation and the possibility of its correction with resverаtrol and nicorandi | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | experimental preeclampsia | ru |
| dc.subject | platelet aggregation | ru |
| dc.subject | hemostasis | ru |
| dc.subject | nicorandil | ru |
| dc.subject | resverаtrol | ru |
| dc.title | L-NAME-induced preeclampsia: correction of functional disorders of the hemostasis system with resveratrol and nicorandil | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 5, № 2
|
